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Background: Anxiety and depression are the most common psychiatric disorders and are the cause of a large and
increasing amount of sick-leave in most developed countries. They are also implicated as an increasing mortality
risk in community surveys. In this study we addressed, whether sick leave due to anxiety, depression or comorbid
anxiety and depression was associated with increased risk of retirement due to permanent disability and increased
mortality in a cohort of German workers.
Methods: 128,001 German workers with statutory health insurance were followed for a mean of 6.4 years. We
examined the associations between 1) depression/anxiety-related sick leave managed on an outpatient basis and 2)
anxiety/depression-related psychiatric inpatient treatment, and later permanent disability/mortality using Cox
proportional hazard regression models (stratified by sex and disorder) adjusted for age, education and job code
classification.
Results: Outpatient-managed depression/anxiety-related sick leave was significantly associated with higher
permanent disability (hazard ratio (95% confidence interval)) 1.48 (1.30, 1.69) for depression, 1.25 (1.07, 1.45) for
anxiety, 1.91 (1.56, 2.35) for both). Among outpatients, comorbidly ill men (2.59 (1.97,3.41)) were more likely to retire
early than women (1.42 (1.04,1.93)). Retirement rates were higher for depressive and comorbidly ill patients who
needed inpatient treatment (depression 3.13 (2,51, 3,92), both 3.54 (2.80, 4.48)). Inpatient-treated depression was
also associated with elevated mortality (2.50 (1.80, 3.48)). Anxiety (0.53 (0.38, 0.73)) and female outpatients with
depression (0.61 (0.38, 0.97)) had reduced mortality compared to controls.
Conclusions: Depression/anxiety diagnoses increase the risk of early retirement; comorbidity and severity further
increase that risk, depression more strikingly than anxiety. Sickness-absence diagnoses of anxiety/depression
identified a population at high risk of retiring early due to ill health, suggesting a target group for the development
of interventions.
Keywords: Anxiety, Depression, Treatment, Invalidity, Mortality, Occupational disability, Protection* Correspondence: wedegaertner.felix@mh-hannover.de
1Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover
Medical School, Centre for Mental Health, Carl-Neuberg-Str. 1, 30625,
Hannover, Germany
Full list of author information is available at the end of the article
© 2013 Wedegaertner et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Wedegaertner et al. BMC Public Health 2013, 13:145 Page 2 of 10
http://www.biomedcentral.com/1471-2458/13/145Background
Anxiety and depression are common, overlapping mental
disorders. They are important causes of absence from
work and permanent disability [1-3]. Depression is one of
the main contributors to disability worldwide [4]. It is a
predominantly chronic recurrent disease which often leads
to long periods of work incapacity [5]. Depression in
working age adults generates direct costs in the field of
health insurance and indirect costs from lost working
hours, loss of lifetime income, and early retirement [6-8].
Depression and anxiety are particularly costly to insurers
and these costs are increasing: In the past twenty years, in
Germany the contribution of mental disorders to the costs
of permanent disability pensions has tripled and more
than half of these are caused by depression, anxiety and
related neurotic disorders [9]. Accordingly this issue is of
great interest to insurers and governments [10].
Common mental disorders (measured with question-
naires) have been found to be associated with increased risk
of disability pension awards in representative national
samples of working age adults in Denmark [11] and in a
sample of a single county in Norway [12], but we know of
no study examining the relationship, between people in em-
ployment taking sick leave attributed to these common men-
tal disorders and risk of permanent disability pensioning. It
is this relationship which may interest insurers because of
the opportunity for future early interventions [13].
A large body of literature links depression with
increased mortality [14-17]. Similar relationships have
been reported whether the data were collected,by ques-
tionnaire [18,19] or by psychiatric interview [20], in the
general population or in medically unwell subgroups, or in
samples where ‘unnatural’ causes of death are included or
excluded [20]. The issue of anxiety and mortality has less
consensus: Increased anxiety has been found to be
associated with increasing [21], possibly decreasing [22]
mortality risks. A ‘U-shaped’ mortality curve with increas-
ing severity [23] has also been reported. Adjustment for
anxiety/depression-comorbidity is lacking in most epi-
demiological studies. A large study which could examine
these relationships in the context of this co-morbidity,
with an indication of severity such as whether the patient
ever has inpatient treatment, is therefore justified.
We aimed to determine whether sick leave attributed to
anxiety, depression, or both (and whether treatment was
outpatient-only or incorporated one or more periods as an
inpatient) was associated with elevated risk of permanent
disability and of mortality in a large sample of workers in
Germany who were customers of a particular health insurer.
Methods
Dataset
We used data from the Mettmann Regional Office of the
AOK Rheinland (a German public health insurancecompany). The following details of insured individuals
were available: data on claims for work incapacity, in-
cluding diagnoses, age, sex, highest attained education,
job code classification and employment status (retired or
employed) and, if applicable, date of death. Workers
who were insured by this company had to provide a
medical certificate by the third day of absence from
work. All medical reasons for work incapacity were
passed on to the insurance company, which also keeps
accurate data about hospital admissions and dates of
death. The period of documentation extended from 1st
January 1987 to 31st October 1996.
Insured individuals were only included in the study if
they had already been insured for a period of at least
365 days and were 15 to 74 years old. Also, only subjects
who had to present a medical certificate when ill were
included, essentially restricting the sample to employees.
Excluded cases consisted mainly of non-working
spouses, older retirees and children.
Causes of death and causes of disability pensioning
were unavailable to us. Therefore all-cause premature
retirement and all-cause mortality were considered in re-
lation to treatment for depression and/or anxiety, either
with or without inpatient treatment.
At the time of data collection, large pension deductions
made it financially unattractive to retire before age 58
without a demonstrated health reason: In this age group,
disability pensions outnumber old-age pensions by 1000:1
[24,25]. At age 58 or older, the specifics of the regulatory
situation in Germany at that time meant that individuals
may have been declared to be retiring when a more accur-
ate explanation would be redundancy or other non-health
related causes of permanently ending work. Therefore re-
tirement from the age of 15 to 57 years is used to describe
retirement due to permanent disability in this study.
Independent variables
Subjects were considered to have anxiety or depression
if they had any of the following:
I. Depression
Major depression, single episode (ICD-9 296.2)
Major depression, recurrent episode (ICD-9 296.3)
Reactive depressive episode (ICD-9 298.0)
Neurotic depression (ICD-9 300.4)
Brief depressive reaction (ICD-9 309.0)
Prolonged depressive reaction (ICD-9 309.1)
Depressive conditions not elsewhere classified (ICD-9 311)II.Anxiety
Anxiety states, unspecified (ICD-9 300.0)
The main independent variables of interest were 1.)
anxiety/depression-related sick leave managed on an
Wedegaertner et al. BMC Public Health 2013, 13:145 Page 3 of 10
http://www.biomedcentral.com/1471-2458/13/145outpatient basis, in either primary care or specialist
centres, and 2.) anxiety/depression related psychiatric in-
patient treatment. The insured individuals were classi-
fied as “outpatient-managed sick leave” if at least one
period of absence from work resulted from the above
conditions without an inpatient psychiatric stay. A case
of inpatient treatment was defined by at least one in-
patient psychiatric stay with one of the above conditions
documented (regardless of whether it was preceded or
followed by sick-leave managed as an outpatient).
Controls were all subjects those with neither of these
events. Inpatient psychiatric treatments included treatments
in specialist mixed neurological- psychiatric departments
and those that began in other medical clinics and led to
the patient being transferred to inpatient psychiatric
treatment.
Dependent variables
The dependent variables were: 1.) retirement before age
58, 2.) death from any cause.
Analyses
Statistical analyses were performed with PASW/SPSS
Version 18. Kaplan-Meier curves can be seen in the
Additional files.
Time-at-risk started when observation began. The time-
at-risk ended with the death of the participant, retirement
before age 58 or when observation ended. Cox propor-
tional hazards regression models were built to compare
the mortality/disability risks of “case” participants with
that of the controls (those with no [outpatient or in-
patient] anxiety/depression-related sick leave at any point).
We carried out separate analyses for “anxiety outpatient”,
“anxiety inpatient”, “depression outpatient” and “depres-
sion inpatient” groups, each against the control group.
Models were built separately for men and women and
adjusted for age, education and job code classification
(crude estimates are available in the Additional file 1:
Table S1). Interactions between sex and the independent
variables of interest were tested for. Legal basis of data
transmission for the purpose of this study was section 287
of the Fifth Book of the German Social Code. No
individuals were examined for this study so ethics com-
mittee approval was not sought.
Results
Characteristics of the sample
In total, the insurance records of 417,496 individuals
were available. Of those, 4,837 had missing data, 102,102
had not been insured for a minimum of 365 days, 98,637
were under 15 or over 74 years of age, and 83,919
records pertained to individuals who were not under any
obligation to present a medical certificate if they fell ill.
The remaining 128,001 records were used for theanalysis of mortality (Table 1). Of these 125,019 were 57 -
years old and younger at the beginning of the period of
observation. The mean observation period was 6.4 years.
The age and sex distribution as well as the proportion of
employees in the sample were consistent with the distri-
bution of employees with statutory health insurance in
Germany during the period of observation [26]. Women
were more likely to have outpatient-managed sick leave
for depression, anxiety or both (OR = 2.4, Χ2 = 644.7,
p < 0.001, OR= 2.4, Χ2 = 631.5, p < 0.001, OR = 2.8, Χ2 =
313.2, p < 0.001). The same is true for inpatient treat-
ment (OR = 1.4, Χ2 = 16.6, p < 0.001, OR = 2.3, Χ2 =
82.9, p < 0.001, OR = 2.0, Χ2 = 68.6, p < 0.001) (Table 2).
Frequencies and person years at risk for the respec-
tive subsamples can be seen in Table 2.Depression or anxiety as predictors of permanent disability
Risks of premature retirement are increased for all the
case groups compared to controls. In multivariate
adjusted analysis, persons treated for comorbid depres-
sion and anxiety in an inpatient setting had a higher risk
of permanent disability (Hazard ratio (HR) 95% Confidence
Interval (CI) = 4.1(3.0, 5.7) for males, HR = 3.0(2.1, 4.2) for
females, see Table 3). They were followed by depression
inpatients (HR[males] = 3.8(2.8, 5.0), HR[females] = 2.5(1.7,
3.6)) and outpatients in this order (HR[males] = 1.7(1.4,
2.0), HR[females] = 1.3(1.1, 1.6)). The interaction test com-
paring the outcome for males and females was only signifi-
cant in subjects with anxiety/depression comorbidity
treated as outpatients, A visual representation of this gra-
dient can be seen in Kaplan-Meier curves (see Additional
file 2: Figure S1 and Additional file 3: Figure S2).
Anxiety without inpatient stay was connected with a
statistically significant risk of premature disability retire-
ment HR = 1.3(1.01, 1.48). Inpatient stays for anxiety
were not significantly related to increased retirement
rates, but case numbers were low, which limited the
power of analysis, and the estimates were similar to
those of outpatients.Depression or anxiety as predictors for mortality
Markedly increased mortality risks compared to controls
were found for patients who received inpatient treat-
ment for depression (HR = 2.50(1.80, 3.48)). Further, of
those subjects who died during the period of observa-
tion, depressed males with inpatient treatment had the
lowest median age of death (47.5 years) compared to
controls (57.0 years). Decreased mortality was found for
female outpatients who suffered from anxiety (HR = 0.36
(0.19, 0.70)), depression (HR = 0.61 (0.38, 0.97)) or both
(HR = 0.21 (0.05, 0.82)) as well as male outpatients with
anxiety (HR 0.62 (0.43, 0.90)) or both depression and
anxiety (HR = 0.42 (0.20, 0.88)) (see Table 4).
Table 1 Descriptive statistics of the sample
Variable Value
Observed number 128,001 (all employed persons)
Mean observation period 2350 days (6.4 years)
Gender Male 85,502 66.8%
Female 42,499 33.2%
Education General school certificate (9 years of schooling) 40,498 31.6%
Intermediate secondary school certificate (10 yrs of schooling) 52,208 40.8%
Qualifying high school degree (13 years of schooling) 2,786 2.2%
University degree 1,090 0.9%
Not known 29,271 22.9%
Occupation Occupations with little or no qualification 57,097 57.9%
Qualified manual occupations, skilled workers 28,778 29.1%
Qualified white-collar occupations 11,700 11.9%
Middle-management and management positions 1,155 1.2%
Not known 29,271 22.9%
Age at first work incapacity with study diagnosis 39.7 years (n = 4,611)
Age at first inpatient treatment with study diagnosis 38.3 years (n = 840)
Age at early mortality 54.8 years (n = 3,284)
Age at early retirement 49.8 years (n = 5,282)
Table 2 Sample subgroup sizes and frequency of the endpoints
Endpoint Early retirement Early mortality






Men Depression Outpatient 11,672 1,551 116 (7%) 11,749 1,564 45 (3%)
Inpatient 2,416 323 49 (15%) 2,426 325 24 (7%)
Anxiety Outpatient 11,924 1,559 75 (5%) 11,977 1,566 28 (2%)
Inpatient 1,550 209 12 (6%) 1,584 213 11 (5%)
Both Outpatient 3,731 475 52 (11%) 3,742 477 7 (1%)
Inpatient 2,166 272 39 (14%) 2,179 274 12 (4%)
Controls None 504,369 78,867 3,071 (4%) 521,723 81,083 2,564 (3%)
Women Depression Outpatient 13,735 1,736 120 (7%) 13,782 1,741 18 (1%)
Inpatient 1,646 212 29 (14%) 1,671 216 12 (6%)
Anxiety Outpatient 13,159 1,725 101 (6%) 13,195 1,730 9 (1%)
Inpatient 1,782 226 15 (7%) 1806 230 2 (1%)
Both Outpatient 5,085 624 42 (7%) 5,092 625 2 (0%)
Inpatient 2,155 258 32 (12%) 2,155 258 1 (0%)
Controls None 234,094 36,982 1,529 (4%) 239,892 37,699 549 (1%)
Men & women Depression Outpatient 25,407 3,287 236 (7%) 25,531 3,305 63 (2%)
Inpatient 4,062 535 78 (15%) 4,097 541 36 (7%)
Anxiety Outpatient 25,083 3,284 176 (5%) 25,172 3,296 37 (1%)
Inpatient 3,332 435 27 (6%) 3,390 443 13 (3%)
Both Outpatient 8,816 1,099 94 (9%) 8,834 1,102 9 (1%)
Inpatient 4,321 530 71 (13%) 4,334 532 13 (2%)
Controls None 738,463 115,849 4,600 (4%) 761,615 118,782 3,113 (3%)
Total 809,484 125,019 5282 (4%) 832,973 128,001 3,284 (3%)
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Table 3 Permanent disability risks of depression and anxiety patients
Gender Illness Type of management Hazard ratio Confidence interval Significance
Men Anxiety Outpatient only 1.178 0.937, 1.481 P = 0.161
Inpatient 1.285 0.729, 2.266 P = 0.386
Depression Outpatient only 1.698 1.410, 2.044 P < 0.001
Inpatient 3.775 2.845, 5.009 P < 0.001
Both Outpatient only 2.592* 1.970, 3.410 P < 0.001
Inpatient 4.134 3.012, 5.674 P < 0.001
Women Anxiety Outpatient only 1.299 1.062, 1.589 P = 0.011
Inpatient 1.271 0.764, 2.114 P = 0.356
Depression Outpatient only 1.310 1.087, 1.579 P = 0.005
Inpatient 2.464 1.705, 3.560 P < 0.001
Both Outpatient only 1.419* 1.044, 1.930 P = 0.026
Inpatient 2.957 2.082, 4.201 P < 0.001
Men & women Anxiety Outpatient only 1.246 1.071, 1.450 P = 0.004
Inpatient 1.262 0.864, 1.843 P = 0.228
Depression Outpatient only 1.484 1.301, 1.693 P < 0.001
Inpatient 3.130 2.501, 3.917 P < 0.001
Both Outpatient only 1.911* 1.557, 2.346 P < 0.001
Inpatient 3.540 2.798, 4.479 P < 0.001
* Denotes significant interaction by sex at 5% level.
Bold type of results denotes statistical significance at 5% level.
Table 4 Risk of early mortality of anxiety and depression patients
Gender Illness Type of management Hazard ratio Confidence interval Significance
Men Anxiety Outpatient only 0.619 0.427, 0.899 P = 0.012
Inpatient 1.579 0.873, 2.857 P = 0.131
Depression Outpatient only 0.910 0.677, 1.222 P = 0.529
Inpatient 2.394 1.601, 3.581 P < 0.001
Both Outpatient only 0.418 0.199, 0.878 P = 0.021
Inpatient 1.587 0.899, 2.801 P = 0.111
Women Anxiety Outpatient only 0.362 0.187, 0.700 P = 0.003
Inpatient 0.475 0.119, 1.907 P = 0.294
Depression Outpatient only 0.607 0.379, 0.972 P = 0.038
Inpatient 2.686 1.514, 4.765 P = 0.001
Both Outpatient only 0.205 0.051, 0.824 P = 0.026
Inpatient 0.266 0.037, 1.896 P = 0.186
Men & women Anxiety Outpatient only 0.529 0.383, 0.733 P < 0.001
Inpatient 1.182 0.685, 2.038 P = 0.549
Depression Outpatient only 0.798 0.621, 1.026 P = 0.078
Inpatient 2.504 1.802, 3.481 P < 0.001
Both Outpatient only 0.343 0.178, 0.660 P = 0.001
Inpatient 1.162 0.673, 2.005 P = 0.590
Bold type of results denotes statistical significance at 5% level.
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advantages can most easily be seen in the middle
decades of life (see Additional file 4: Figure S3). Con-
versely, all three curves plotting survival of patients with
inpatient treatment show increased mortality risks
compared to controls, for both males and females (See
Additional file 5: Figure S4).
Discussion
Three main contrasts can be seen in the results. Firstly,
depression was associated with a raised risk of early re-
tirement due to permanent disability, but anxiety had a
less pronounced effect. Patients who required inpatient
treatment for depression had worse outcomes than those
who did not. This was not true for anxiety, where there
was no compelling severity-response effect. Co-morbid
depression and anxiety both had a greater effect than ei-
ther disorder alone.
Secondly, male patients seemed to have a worse out-
come from these disorders in terms of permanent disabil-
ity than female patients, though the prevalences of both of
the diagnoses and of comorbidity, was lower in males. The
hazard ratio for males was significantly greater than that
for females in comorbidly ill patients with outpatient-
managed sick leave (though we acknowledge the problems
of interpretation of interactions where both estimates are
the same side of the null value [27]).
Thirdly, there were significantly reduced mortality
risks for outpatient-only anxiety and co-morbidity in
males and females, and for females only for depression.
Depression or anxiety as predictors of permanent disability
We have shown the marked effects of depression and
anxiety on participation in working life in Germany, in a
large sample, where degree of impairment is indexed by
whether a patient was ever treated as an inpatient or
solely managed as an outpatient with sick-leave. Both
outpatient sick-leave and inpatient treatments are ac-
companied by a elevated probability of permanent with-
drawal from the workplace. For younger people suffering
from depression, the consequences may be dramatic, as
retirement at a young age is likely to be associated with
a markedly reduced lifetime income [28].
As expected, the effect was more pronounced for
patients treated on an inpatient basis (an indicator of
greater severity), consistent with there being a dose–
response relationship between severity of depression and
both the outcomes. Also as expected, depression was
diagnosed more often in women than in men (see Table 2).
Retirement rates for depressed men appeared to be higher
than those for women, however. And this may be because
men are only put on sick leave or seek treatment for de-
pression when they are more severely impaired [29]. ln
northern European countries the way in which some mendescribe depressive symptoms may impair them being
diagnosed with depression [30], and gender-specific mis-
classification to the disadvantage of male patients may also
play a role [31]. Alternatively, the threshold at which help
is received may be higher. Another explanation may be
that personal, cultural (and medical) expectations of mood
state differ between the sexes. It has been shown that
health anxiety is a strong, independent, and yet under
recognized risk factor for permanent disability pension
[32]. We were unable to differentiate between anxiety
forms, so it may be that the subsample of anxiety patients
is heterogeneous. Detecting health anxiety may be a tool to
differentiate at an early stage between those cases of anx-
iety which are more likely to lead to permanent disability.
The markedly elevated early retirement rates for both
sexes after inpatient treatment suggest that inpatient
services should be focussed on occupational reintegra-
tion, especially when planning the post-hospitalisation
treatment phase in younger adults. Mental health
workers should be aware that inpatient treatment of de-
pression has great implications for further participation
in working life, with 14% of males in our sample
hospitalised with comorbid depression and anxiety per-
manently ending their working lives aged 57 or less.
Depression or anxiety as predictors of mortality
The excess mortality of depression and anxiety differs
very strongly dependent on study design and case defin-
ition. Hazard ratios of 1.4 for women and 1.5 for men
(natural causes only – excluding suicide, homicide and
accident) [18,33], and 2.1 (women) and 2.7 (men) [34]
have been reported. In addition, depressed patients have
highly elevated risks of unnatural deaths [35]. The esti-
mate we found of the excess mortality in the inpatient
sample here was similar, but changed when patients with
anxiety were removed from the depressed sample.
It is of particular interest that depression and anxiety
associated with outpatient-managed sick leave are
associated with reduced mortality, seemingly in the earl-
ier decades of life, more prominently among women, but
also among men. The key to understanding this
phenomenon may lie in the predominant causes of death
in early decades of life. In the first five decades of life,
overall mortality is low and unnatural causes of death
(such as accidents, suicides and homicide) are respon-
sible for much of the mortality, up to 30% depending on
age [36]. Cardiovascular diseases and neoplasms, which
are responsible for the greater part of mortality in
advanced age and for which an association with depres-
sion has been demonstrated [37,38], only play a subor-
dinate role at a young age. It is known that inpatient
treatment for depression may be accompanied with six-
teen fold increased mortality due to suicide [35]. This
proved to be strongly linked to depression severity. There
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be associated with increased suicide rates [39]. High trait
anxiety (on several measures) has been found to be
associated with reduced mortality in younger British born
adults, and increased mortality later in life, following the
pattern proposed above. Deaths from injuries are reduced
in younger participants, and deaths from medical causes
are later increased [40], and these aspects may explain
these differences in mortality between strata.
It is possible that mild depression, or its treatment with
antidepressants, has a causal effect on mortality. Here,
presumably depressed individuals behave differently to
their well counterparts, by taking fewer direct risks and
possibly caring for their health more diligently. This could
be driven by seeing their situation with ‘Depressive Real-
ism’ [41]), or simply that the inactivity seen in depressed
people may be incidentally protective in that age group.
Finally there is the reported cardioprotective effects of the
class of antidepressant drug known as specific serotonin
uptake inhibitors (SSRIs) which may play a role [42].
Strengths and weaknesses
Representativeness
The observations were made in a West-German popula-
tion during a period that saw both a phase of economic
boom and a phase of stagnation. There were no major legal
changes in access to retirement pensions during the obser-
vation period, so cohort effects whereby major legal
changes could affect both diagnosis of mental disorder and
permanent disability/mortality are unlikely. Similarly,
trends in mental disorder prevalence and permanent dis-
ability incidence could create spurious findings in a cross-
sectional study, a prospective cohort study such as this is
not vulnerable to such effects Between eighty-five and
ninety percent of all inhabitants of Germany have statutory
health insurance so the used data set had high representa-
tiveness. The dataset was also largely complete with very
few (<1%) missing data-points. Not only was every health
service usage episode taken up in the observation period
documented, but also the most important social data such
as occupation, education, level of income, type of income
and, where appropriate, date of retirement and death are
routinely collected and so were available. Because payment
for organisations and access to care for individuals depends
on collection of these data, they were likely to be diligently
recorded. The main advantages of this method are the
large case numbers and the fact that the complete dataset
effectively includes the control group. Therefore there was
no differential recruitment which may have caused recruit-
ment bias. A particular advantage was also being able to
record very short work incapacity periods here, which
made it possible to detect milder episodes of illness.
An explanation for the apparent advantages of depres-
sion and anxiety on mortality (but not early retirement)in younger decades could also be a ‘healthy presenter’ ef-
fect whereby the depressed younger people who attend
their doctors are physically healthier than other
depressed people who do not. This is in contrast to the
inpatient group, where one expects nearly all people
with depression of this severity to be included. This as-
sumption requires the established relationships of phys-
ical ill-health with depression [33,43-45], and also that
between primary-care attendance and depression [46], to
be absent, reversed or overwhelmed in the younger part
of this sample. Alternatively patients with additional risk
factors for early mortality may be more likely to be
treated as inpatients than outpatients due to poor phys-
ical health, home circumstances, comorbidity with alco-
hol problems, and other factors.
Another source of error may be the control group. In
the group of people who had never had a any time off
work for depression and anxiety may be people who are
avoidant of healthcare in general. These individuals may
suffer increased mortality later in life because of this ra-
ther than their ‘non-diseased’ status.
Participation biases
As a result of the social structure of the employees
insured by the AOK, the insured individuals as a whole
differ from the general population with regard to social
status and disease burden [47]. Occupations involving
simple manual jobs and individuals with a low to moder-
ate level of education were predominant. With regard to
gender distribution, there is a slight displacement in
favour of men in the sample. In the working population,
the ratio of men to women in the period of data collec-
tion was 60:40 [26]. The former effect is likely to cause
an underestimate of any association because of the ob-
servation that low social status is accompanied by an
increased disease burden and resulting disability pension
award. Further, our estimates are consistent with the lit-
erature, though they are not always significant [48,49].
Another weakness is that this study did not include
people who were unemployed, as they were not included
in the study sample. These people were excluded, be-
cause they were not obliged to present a medical certifi-
cate if taken ill, so no diagnostic data were available.
Information biases
Is unknown to what extent doctors did not issue a de-
pressive/anxiety diagnoses during sick leave for fear of
stigmatization of the patient, or whether this was differ-
ential by gender [31]. There may therefore have been
cases which were not detected by our methods, but the
prevalence of being depressed in this sample was 2.4%
for men and 5,3% for women, suggesting not many cases
were missed, taking into account the low prevalence of
psychiatric disorders expected in a working population.
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primary care [5], and it is likely that the we missed some
cases of mild disorder. This may have caused us to over-
estimate the effects because of the under-representation
of the milder cases of disorder, which presumably are
less related to the outcomes.
Limitations of secondary data analysis and statistical power
Given case numbers in the hundreds of thousands, it be-
came clear in this study that due to restriction and low
event frequency the individual categories quickly became
so small that further stratification was not appropriate.
Another disadvantage was that, as is inevitable in a cohort
study, causation cannot be determined unequivocally
from the dataset because of residual or unconsidered
confounding.
An intrinsic problem of secondary data analysis of
statutory health insurance data is that different doctors
have different thresholds for applying the same diagnos-
tic code [50]. Although inpatient treatments and work
incapacity diagnoses have been an inherent part of
health reporting for many years, diagnostic quality can
only be regarded as sufficient on the level of large dis-
ease entities [51]. Thus we used large disease entities as
the exposure measures for this study.
As has been noted, the control group included
subclinically depressed or anxious patients, those who
seek treatment but have no sick leave because of their dis-
order, and those who attended their doctors with depres-
sion or anxiety but were diagnosed with something else
for whatever reason. Subclinical depression (causing no
identified sickness absence from work) may have an effect
on early retirement [52,53] but its prevalence is unknown,
not only in this sample. So it is impossible to deduce the
additional risks associated with depression and anxiety as
a whole for mortality and permanent disability from the
parameters used in this study. The point prevalence of de-
pressive disorders in Germany was stated as 6.4% in the
last systematic survey in the German-speaking countries
in 1998 [54], compared with 4.2% in Europe in 2003 [55].
Newer data suggests a point prevalence of depression in
Germany of 8.6% for women and 4.5% for men [56]. These
figures are compatible with there having been no trend in
depression prevalence in Germany in recent years. In the
sample of this study the six-year prevalence was 2.4% for
men and 5,3% for women. The differences are explicable
by the tighter criteria in this study, but they suggesting
there are many cases of depression which did not cause
identified sickness absence, leading to an underestimation
of the effect of anxiety and depression as a whole.
The probability of early retirement occurring is largely
affected by legal regulations. For this reason it was import-
ant for the authors to choose an observation period that
was before the abolition of the statutory occupationaldisability pension, which was the 1st January 2001 and
changes in the interaction of unemployment benefits and
retirement for older employees on 1st January 2003. Diag-
nostic data from outpatient treatment – and not only
outpatient-managed sick leave - have been reported to the
health insurance companies again in relation to individual
insured persons since 2004 and the implementation of the
two bodies of legislation has been completed, there is a de-
sire for more differentiated analysis with newer data. How-
ever, the endpoints used here can only be used again with
restrictions: The further the abolition of the statutory oc-
cupational disability insurance lies in the past, the less the
pension claims statistics reflect real burden of permanent
disability, which is now increasingly removed from the
official statistics as a privately insured issue.
Conclusions
We were able to find a strong dose–response relation-
ship of disease management mode and anxiety/
depression comorbidity with permanent disability. While
depression appeared to influence mortality and perman-
ent disability in the same direction, this was not the case
for anxiety. To an unknown extent, lifestyle factors, ser-
vice use and physical comorbidities influenced disable-
ment or death in the present study. A better insight into
the causal relationships between depression, anxiety and
outcome, with particular focus on the positive outcomes,
is necessary and warrants further study. No increased
mortality could be determined for patients who only had
outpatient-managed sick leave for depression or anxiety,
which means that we found no reason for these patients
to be treated differently by life-insurers.
Statutory health insurance data on anxiety and depres-
sion cases associated with sick leave is useful to identify
people at elevated risk of disability or mortality who
might not otherwise come to clinical attention. Health
policy-makers, increasingly interested in preventing
sickness-absence from becoming long-term or perman-
ent may like to consider testing interventions focused on
preserving and restoring occupational functioning, in
groups presenting requests to be certified as unfit for
work with depression and/or anxiety.
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